RE: [MOL] Nanc to Mam......about inhalers! [02990] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

RE: [MOL] Nanc to Mam......about inhalers!



Title: RE: [MOL] Nanc to Mam......about inhalers!

Dear Nanc:  The Rose kids look much better now, and they're a bunch of real cuties!  Love, Kathy

-----Original Message-----
From: owner-mol-cancer@lists.meds.com
[mailto:owner-mol-cancer@lists.meds.com]On Behalf Of NLPOST@AOL.COM
Sent: Tuesday, February 23, 1999 10:45 AM
To: mol-cancer@lists.meds.com
Subject: Re: [MOL] Nanc to Mam......about inhalers!


Thanks Mam,
For the information.  I got the Rose kids looking better in the album, take a
look.
Love ya,
Nanc  :-)

In a message dated 2/23/99 7:04:33 AM Eastern Standard Time,
FEARME@bigpond.com writes:

<< Dear Nance,
 Albuterol is in the class of sympathomimetic drugs. What this means is
 they have a wider range of use than just salbutamol (ventolin), which
 acts specifically as a broncho-dilater. (In other words, opens up the
 air passages in the lungs). Albuterol also has an effect on the eyes, in
 that it helps to lower intr-ocular pressure, and may also have an effect
 on the heart, helping it to contract correctly. Now usually, you would
 take different medications for each problem, but it is my understanding
 that albuterol could help in all these instances, and if you aren't
 experiencing any side effects, then I would stay with it.
 hope this helps,
 much love,
 Mam >>
------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------